| 0.2918 -0.024 (-7.66%) | 06-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.15 | 1-year : | 3.29 |
| Resists | First : | 1.84 | Second : | 2.82 |
| Pivot price | 1.09 |
|||
| Supports | First : | 0.25 | Second : | 0.2 |
| MAs | MA(5) : | 0.3 |
MA(20) : | 1.45 |
| MA(100) : | 2.23 |
MA(250) : | 0 | |
| MACD | MACD : | -0.6 |
Signal : | -0.5 |
| %K %D | K(14,3) : | 2.1 |
D(3) : | 2.2 |
| RSI | RSI(14): 19.1 |
|||
| 52-week | High : | 7.39 | Low : | 0.25 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ POAS ] has closed above bottom band by 31.3%. Bollinger Bands are 74.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.34 - 0.34 | 0.34 - 0.34 |
| Low: | 0.27 - 0.27 | 0.27 - 0.28 |
| Close: | 0.31 - 0.32 | 0.32 - 0.32 |
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
Fri, 05 Jun 2026
POAS Should I Buy - Intellectia AI
Wed, 03 Jun 2026
Phaos Technology Holdings (Cayman) Limited Provides Updated Response to Unusual Market Action - The Manila Times
Wed, 03 Jun 2026
Phaos Technology can't find cause of unusual NYSE trading - Stock Titan
Fri, 13 Feb 2026
POAS Technical Analysis & Stock Price Forecast - Intellectia AI
Fri, 16 Jan 2026
Phaos Technology (POAS) CEO and COO exit as Gan Hong Loon becomes interim CEO - Stock Titan
Fri, 16 Jan 2026
Phaos Technology Holdings Limited Announces CEO Changes, Effective December 31, 2025 - marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|